vs
Side-by-side financial comparison of Brainsway Ltd. (BWAY) and GLAUKOS Corp (GKOS). Click either name above to swap in a different company.
BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem.
Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $143.1M | ||
| Q3 25 | — | $133.5M | ||
| Q2 25 | — | $124.1M | ||
| Q1 25 | — | $106.7M | ||
| Q4 24 | — | $105.5M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $95.7M | ||
| Q1 24 | — | $85.6M |
| Q4 25 | — | $-133.7M | ||
| Q3 25 | — | $-16.2M | ||
| Q2 25 | — | $-19.7M | ||
| Q1 25 | — | $-18.1M | ||
| Q4 24 | — | $-33.6M | ||
| Q3 24 | — | $-21.4M | ||
| Q2 24 | — | $-50.5M | ||
| Q1 24 | — | $-40.8M |
| Q4 25 | — | -1.1% | ||
| Q3 25 | — | 78.4% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 77.2% | ||
| Q4 24 | — | 72.9% | ||
| Q3 24 | — | 76.6% | ||
| Q2 24 | — | 76.4% | ||
| Q1 24 | — | 76.3% |
| Q4 25 | — | -97.7% | ||
| Q3 25 | — | -12.3% | ||
| Q2 25 | — | -18.3% | ||
| Q1 25 | — | -19.4% | ||
| Q4 24 | — | -27.2% | ||
| Q3 24 | — | -25.5% | ||
| Q2 24 | — | -31.3% | ||
| Q1 24 | — | -45.6% |
| Q4 25 | — | -93.4% | ||
| Q3 25 | — | -12.2% | ||
| Q2 25 | — | -15.8% | ||
| Q1 25 | — | -17.0% | ||
| Q4 24 | — | -31.8% | ||
| Q3 24 | — | -22.1% | ||
| Q2 24 | — | -52.8% | ||
| Q1 24 | — | -47.7% |
| Q4 25 | — | $-2.34 | ||
| Q3 25 | — | $-0.28 | ||
| Q2 25 | — | $-0.34 | ||
| Q1 25 | — | $-0.32 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | — | $-0.39 | ||
| Q2 24 | — | $-1.00 | ||
| Q1 24 | — | $-0.82 |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
